Pharmaceutical stocks, including Pfizer (NYSE: PFE), have recently been scrutinized after President Trump’s executive order instructing drug manufacturers to reduce medicine prices to align with ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE) have recently come under scrutiny following President Trump’s executive order directing drugmakers to lower medicine prices to match what ...

Transparency Talks will bring together leaders from Model N, Pfizer and Global Pricing Innovations (GPI) to explore state drug pricing laws and regulations, as well as facilitate a discussion on ...

Drugmakers Pfizer and Flynn Pharma have been ... so they were no longer subject to price regulations. Pfizer hiked the price of the drug between 780% and 1,600%, and also supplied the drug to ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Pfizer’s oncology chief has warned that the Biden administration’s drug price reforms could hurt ...

Pfizer plans to charge COVID patients around ... Wednesday to pharmacies and clinics announcing the $1,390 price tag for the drug, which was the first oral treatment for COVID approved by the ...

Pfizer will price a five-day course of its Covid antiviral drug Paxlovid at $1,390 when the company starts to transition it to the commercial market later this year. A company spokesperson on ...

Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the US on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis ...

Notable medicines subject to price increases include Pfizer’s COVID-19 drug Paxlovid, Bristol Myers Squibb’s CAR-T therapies Abecma and Breyanzi and a clutch of vaccines from Sanofi ...

He and other physicians had warned that an increase in Paxlovid’s price would create hurdles for people to get the drug. Pfizer said Paxlovid “has been a breakthrough in the fight against ...

Pfizer on Wednesday revealed that it raised the list price of a course of Paxlovid—its lifesaving antiviral drug used to reduce the risk of severe COVID-19 in those most vulnerable—to nearly $ ...

Pfizer Inc. and Flynn Pharma Ltd. were fined a combined £70 million ($83.6 million) after UK antitrust authorities said the firms charged “unfairly high prices” for a drug used to control ...